<DOC>
	<DOCNO>NCT02736357</DOCNO>
	<brief_summary>The goal infrastructure grant establish maintain cohort 12,000 non-Hodgkin lymphoma ( NHL ) patient support broad cutting-edge research identify clinical ( include co-morbid disease ) , epidemiologic ( include lifestyle exposure ) , host genetic , tumor , treatment factor , well interaction among factor , short long-term outcome . These effort identify new approach improve survival well-being NHL patient .</brief_summary>
	<brief_title>The Lymphoma Epidemiology Outcomes ( LEO ) Cohort Study</brief_title>
	<detailed_description>Newly diagnose non-Hodgkin lymphoma ( NHL ) patient recruit center participate LEO cohort . At time consent , participant ask complete several questionnaire collect health history , current medical quality life question . Patients also provide baseline blood sample process locally store centrally future research use . Additionally , consent give use excess clinical tumor tissue research use .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Newly diagnose nonHodgkin Lymphoma ( NHL ) , within 183 day enrollment Patients may treat long initial NHL diagnosis within 6 month enrollment 18 year age old Lymphoma diagnosis great 184 day date consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>Cohort</keyword>
	<keyword>non-Hodgkin</keyword>
</DOC>